XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.2
Investments
6 Months Ended
Jun. 30, 2019
Investments [Abstract]  
Investments

2.     INVESTMENTS



The Company’s investments are primarily composed of fixed income debt securities and common and preferred stock equity securities. We carry our equity securities at fair value and categorize all of our fixed maturity debt securities as available-for-sale (AFS), which are carried at fair value. When available, quoted market prices are obtained to determine fair value for the Company’s investments. If a quoted market price is not available, fair value is estimated using a secondary pricing source or using quoted market prices of similar securities. The Company has no investment securities for which fair value is determined using Level 3 inputs as defined in Note 3 – Fair Value Disclosures. Realized gains and losses on disposition of investments are based on specific identification of the investments sold on the settlement date, which does not differ significantly from trade date accounting.



Available-for-Sale Fixed Maturity and Equity Securities



The following tables are a summary of the proceeds from sales, maturities, and calls of available-for-sale fixed maturity and equity securities and the related gross realized gains and losses.







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

For the Three-Months Ended June 30,



 

 

 

 

 

 

 

 

 

 

Net realized



 

Proceeds

 

Gains

 

Losses

 

gain / (Loss)

2019

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities

 

$

7,971,580 

 

$

139,703 

 

$

(4,530)

 

$

135,173 

Common stocks

 

 

4,124,060 

 

 

711,524 

 

 

(199,629)

 

 

511,895 

2018

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities

 

$

2,598,335 

 

$

4,669 

 

$

(13,084)

 

$

(8,415)

Common stocks

 

 

241,047 

 

 

16,473 

 

 

(37,988)

 

 

(21,515)













 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

For the Six-Months Ended June 30,



 

 

 

 

 

 

 

 

 

 

Net realized



 

Proceeds

 

Gains

 

Losses

 

gain

2019

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities

 

$

13,750,473 

 

$

165,292 

 

$

(16,149)

 

$

149,143 

Common stocks

 

 

4,677,473 

 

 

775,101 

 

 

(324,602)

 

 

450,499 

2018

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities

 

$

6,669,276 

 

$

52,787 

 

$

(26,115)

 

$

26,672 

Common stocks

 

 

8,834,375 

 

 

1,102,862 

 

 

(62,242)

 

 

1,040,620 

Preferred stocks

 

 

3,861,722 

 

 

86,862 

 

 

(81,954)

 

 

4,908 





The amortized cost and estimated fair value of fixed income securities at June 30, 2019, by contractual maturity, are shown as follows:







 

 

 

 

 

 



 

 

 

 

 

 



 

Amortized Cost

 

Fair Value

Due in one year or less

 

$

1,526,535 

 

$

1,528,049 

Due after one year through five years

 

 

22,200,131 

 

 

22,966,370 

Due after five years through 10 years

 

 

12,710,470 

 

 

13,745,599 

Due after 10 years

 

 

14,381,514 

 

 

15,442,162 

Asset and mortgage backed securities without a specific due date

 

 

37,409,415 

 

 

37,717,192 

Total fixed maturity securities

 

$

88,228,065 

 

$

91,399,372 



Expected maturities may differ from contractual maturities due to call provisions on some existing securities.



The following table is a schedule of cost or amortized cost and estimated fair values of investments in securities classified as available for sale at June 30, 2019 and December 31, 2018:  









 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Cost or

 

 

 

 

Gross Unrealized



 

Amortized Cost

 

Fair Value

 

Gains

 

Losses

2019

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury

 

$

1,349,518 

 

$

1,344,789 

 

$

510 

 

$

(5,239)

MBS/ABS/CMBS

 

 

37,409,415 

 

 

37,717,192 

 

 

460,787 

 

 

(153,010)

Corporate

 

 

37,787,229 

 

 

39,851,430 

 

 

2,066,152 

 

 

(1,951)

Municipal

 

 

11,681,903 

 

 

12,485,961 

 

 

804,058 

 

 

 —

Total AFS securities

 

$

88,228,065 

 

$

91,399,372 

 

$

3,331,507 

 

$

(160,200)







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Cost or

 

 

 

 

Gross Unrealized



 

Amortized Cost

 

Fair Value

 

Gains

 

Losses

2018

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury

 

$

1,348,575 

 

$

1,328,925 

 

$

 —

 

$

(19,650)

MBS/ABS/CMBS

 

 

34,372,133 

 

 

33,799,024 

 

 

33,955 

 

 

(607,064)

Corporate

 

 

37,383,903 

 

 

37,366,690 

 

 

376,029 

 

 

(393,242)

Municipal

 

 

16,148,295 

 

 

16,486,520 

 

 

398,569 

 

 

(60,344)

Total fixed maturity securities

 

 

89,252,906 

 

 

88,981,159 

 

 

808,553 

 

 

(1,080,300)

Equity securities:

 

 

 

 

 

 

 

 

 

 

 

 

Common stocks

 

 

13,572,713 

 

 

11,843,223 

 

 

406,812 

 

 

(2,136,302)

Total equity securities1

 

 

13,572,713 

 

 

11,843,223 

 

 

406,812 

 

 

(2,136,302)

Total AFS securities

 

$

102,825,619 

 

$

100,824,382 

 

$

1,215,365 

 

$

(3,216,602)



1Effective January 1, 2019, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale. Prior periods have not been recast to conform to the current presentation.



All of the Company’s collateralized securities carry an average credit rating of AA+ by one or more major rating agencies and continue to pay according to contractual terms. Included within MBS/ABS/CMBS, as defined in Note 3 – Fair Value Disclosures, are residential mortgage backed securities with fair values of $15,482,344 and $13,696,585 and commercial mortgage backed securities of $12,245,736 and $10,126,352 at June 30, 2019 and December 31, 2018, respectively.

ANALYSIS



The following tables are also used as part of the impairment analysis and displays the total value of securities that were in an unrealized loss position as of June 30, 2019, and December 31, 2018. The tables segregate the securities based on type, noting the fair value, cost (or amortized cost), and unrealized loss on each category of investment as well as in total. The table further classifies the securities based on the length of time they have been in an unrealized loss position.







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

June 30, 2019



 

 

 

 

12 Months

 

 

 



 

< 12 Months

 

& Greater

 

Total

Fixed Maturity Securities:

 

 

 

 

 

 

 

 

 

U.S. Treasury

 

 

 

 

 

 

 

 

 

Fair value

 

$

 —

 

$

1,244,102 

 

$

1,244,102 

Cost or amortized cost

 

 

 —

 

 

1,249,341 

 

 

1,249,341 

Unrealized loss

 

 

 —

 

 

(5,239)

 

 

(5,239)

MBS/ABS/CMBS

 

 

 

 

 

 

 

 

 

Fair value

 

 

6,108,557 

 

 

9,748,934 

 

 

15,857,491 

Cost or amortized cost

 

 

6,123,321 

 

 

9,887,180 

 

 

16,010,501 

Unrealized loss

 

 

(14,764)

 

 

(138,246)

 

 

(153,010)

Corporate

 

 

 

 

 

 

 

 

 

Fair value

 

 

 —

 

 

1,262,184 

 

 

1,262,184 

Cost or amortized cost

 

 

 —

 

 

1,264,135 

 

 

1,264,135 

Unrealized loss

 

 

 —

 

 

(1,951)

 

 

(1,951)

Total debt securities available for sale

 

 

 

 

 

 

 

 

 

Fair value

 

 

6,108,557 

 

 

12,255,220 

 

 

18,363,777 

Cost or amortized cost

 

 

6,123,321 

 

 

12,400,656 

 

 

18,523,977 

Unrealized loss

 

 

(14,764)

 

 

(145,436)

 

 

(160,200)







 

 

 

 

 

 

 

 

 



 

December 31, 2018



 

 

 

 

12 Months

 

 

 



 

< 12 Months

 

& Greater

 

Total

U.S. Treasury

 

 

 

 

 

 

 

 

 

Fair value

 

$

 —

 

$

1,328,925 

 

$

1,328,925 

Cost or amortized cost

 

 

 —

 

 

1,348,575 

 

 

1,348,575 

Unrealized loss

 

 

 —

 

 

(19,650)

 

 

(19,650)

MBS/ABS/CMBS

 

 

 

 

 

 

 

 

 

Fair value

 

 

16,890,857 

 

 

11,956,493 

 

 

28,847,350 

Cost or amortized cost

 

 

17,039,357 

 

 

12,415,057 

 

 

29,454,414 

Unrealized loss

 

 

(148,500)

 

 

(458,564)

 

 

(607,064)

Corporate

 

 

 

 

 

 

 

 

 

Fair value

 

 

14,304,322 

 

 

5,745,289 

 

 

20,049,611 

Cost or amortized cost

 

 

14,550,153 

 

 

5,892,700 

 

 

20,442,853 

Unrealized loss

 

 

(245,831)

 

 

(147,411)

 

 

(393,242)

Municipal

 

 

 

 

 

 

 

 

 

Fair value

 

 

3,069,720 

 

 

838,980 

 

 

3,908,700 

Cost or amortized cost

 

 

3,100,036 

 

 

869,008 

 

 

3,969,044 

Unrealized loss

 

 

(30,316)

 

 

(30,028)

 

 

(60,344)

Subtotal, fixed income

 

 

 

 

 

 

 

 

 

Fair value

 

 

34,264,899 

 

 

19,869,687 

 

 

54,134,586 

Cost or amortized cost

 

 

34,689,546 

 

 

20,525,340 

 

 

55,214,886 

Unrealized loss

 

 

(424,647)

 

 

(655,653)

 

 

(1,080,300)

Common stock1

 

 

 

 

 

 

 

 

 

Fair value

 

 

8,187,764 

 

 

 

 

 

8,187,764 

Cost or amortized cost

 

 

10,324,066 

 

 

 —

 

 

10,324,066 

Unrealized loss

 

 

(2,136,302)

 

 

 —

 

 

(2,136,302)

Total

 

 

 

 

 

 

 

 

 

Fair value

 

 

42,452,663 

 

 

19,869,687 

 

 

62,322,350 

Cost or amortized cost

 

 

45,013,612 

 

 

20,525,340 

 

 

65,538,952 

Unrealized loss

 

$

(2,560,949)

 

$

(655,653)

 

$

(3,216,602)



1Effective January 1, 2019, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale. Prior periods have not been recast to conform to the current presentation.

As of December 31, 2018, the Company held 200 equity securities that were in unrealized loss positions. Of these 200 securities, none were in an unrealized loss position for 12 consecutive months or longer.



The fixed income portfolio contained 39 securities in an unrealized loss position as of June 30, 2019. Of these 39 securities, 30 have been in an unrealized loss position for 12 consecutive months or longer and represent $145,436 in unrealized losses. All fixed income securities in the investment portfolio continue to pay the expected coupon payments under the contractual terms of the securities. Credit-related impairments on fixed income securities that we do not plan to sell, and for which we are not more likely than not to be required to sell, are recognized in net earnings. Any non-credit related impairment is recognized in comprehensive earnings. Based on management’s analysis, the fixed income portfolio is of a high credit quality and it is believed it will recover the amortized cost basis of the fixed income securities. Management monitors the credit quality of the fixed income investments to assess if it is probable that the Company will receive its contractual or estimated cash flows in the form of principal and interest. There were no other-than-temporary impairment losses recognized in net earnings during the first six months ended June 30, 2019. For all fixed income securities at a loss at June 30, 2019, management believes it is probable that the Company will receive all contractual payments in the form of principal and interest. In addition, the Company is not required to, nor does it intend to sell these investments prior to recovering the entire amortized cost basis for each security, which may be maturity. The fixed income securities in an unrealized loss position were not other-than-temporarily impaired at June 30, 2019 and December 31, 2018.



UNREALIZED GAINS AND LOSSES ON EQUITY SECURITIES



The portion of net unrealized losses for the three months ended June 30, 2019 that relates to equity securities held as of June 30, 2019 was $116,691. The portion of net unrealized gains for the six months ended June 30, 2019 that relates to equity securities held as of June 30, 2019 was $1,723,727.



Other Invested Assets



Other invested assets include privately held investments, including membership in the Federal Home Loan Bank of Chicago (FHLBC), which occurred in February 2018. Our investment in FHLBC stock is carried at cost. Due to the nature of our membership in the FHLBC, the carrying amount approximates fair value. As of June 30, 2019, there were no investments pledged as collateral with the FHLBC. There may be investments pledged as collateral with the FHLBC to ensure timely access to the secured lending facility that ownership of FHLBC stock provides. As of and during the six month periods ending June 30, 2019, there were no outstanding borrowings with the FHLBC.